http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80a742561c1d6c2028941064cee9dc7c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hohlfeld |
| name | Reinhard Hohlfeld |
| given-name | Reinhard |
| organization-name | Institute for Clinical Neuroimmunology Ludwig Maximilians University Munich Germany Institute of Clinical Neuroimmunology, Biomedical Center and Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany From the Institute of Clinical Neuroimmunology (J.K.M.N., J.M., N.K., R.H., K.D., E.M.), Ludwig Maximilians University, Munich; Max Planck Institute of Neurobiology (J.K.M.N., J.M., N.K., R.H., K.D., E.M.), Martinsried, Germany; Department of Neurology and Biomedicine (T.D.), University Hospital Basel, Basel, Switzerland; Neuroimmunology Unit (M.K., T.O.), Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Neuroscience (C.L.), University of Glasgow, Glasgow, UK; Department of... 1Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, D-82152 Martinsried, Germany; 3Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University, D-81377 Munich, Germany Institute of Clinical Neuroimmunology Ludwig Maximilians University of Munich and Munich Cluster for Systems Neurology (SyNergy) Munich Germany Institute of Clinical Neuroimmunology University Hospital, Ludwig‐Maximilians‐Universität München Munich Germany; Biomedical Center (BMC), Faculty of Medicine Ludwig‐Maximilians‐Universität München Munich Germany; Munich Cluster for Systems Neurology (SyNergy) Munich Germany Institute of Clinical Neuroimmunology; Medical Campus Großhadern; Ludwig-Maximilians-Universität München; Munich Germany; Munich Cluster for Systems Neurology (SyNergy); Munich Germany Institute of Clinical Neuroimmunology, Ludwig Maximilian University of Munich, Planegg-Martinsried D-82152, Germany;; Munich Cluster for Systems Neurology (SyNergy), Munich D-81377, Germany; Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximilians University, Munich, Germany Munich Cluster for Systems Neurology, Ludwig-Maximilians University, Munich, Germany Institute of Clinical Neuroimmunology; Medical Campus Grosshadern; Ludwig Maximilian University; Munich Germany; Munich Cluster for Systems Neurology (SyNergy); Munich Germany Institute for Clinical Neuroimmunology, Ludwig-Maximilians University Munich, Marchionistrasse 25, D-81377 Munich, Germany. 3Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, 82152 Martinsried, Germany; 4Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University, 81377 Munich, Germany Institute for Clinical Neuroimmunology, University of Munich, Klinikum Grosshadern, Marchioninistr. 15, D-81366, Munich, Germany, hohlfeld@neuro.mpg.de From the *Department of Neuroimmunology and the ‡Department of Neurobiochemistry, Max Planck Institute for Neurobiology, D-82152 Martinsried, Germany; the §Division of Environmental Dermatology and Allergy, Forschungszentrum für Umwelt und Gesundheit (GSF) and Technical University Munich, D-80802 Munich, Germany; ‖Boehringer-Mannheim, D-82372 Penzberg, Germany; the ¶Institute of Neurology, University of Vienna, A-1090 Vienna, Austria; and the **Institute for Clinical Neuroimmunology and Department of Neurology, Ludwig Maximilians University, D-81366 Munich, Germany; From the *Department of Neuroimmunology and the ‡Department of Neurobiochemistry, Max Planck Institute for Neurobiology, D-82152 Martinsried, Germany; the §Division of Environmental Dermatology and Allergy, Forschungszentrum für Umwelt und Gesundheit (GSF) and Technical University Munich, D-80802 Munich, Germany; ‖Boehringer-Mannheim, D-82372 Penzberg, Germany; the ¶Institute of Neurology, University of Vienna, A-1090 Vienna, Austria; and the **Institute for Clinical Neuroimmunology and Department of Neurology, Ludwig Maximilians University, D-81366 Munich, Germany Institute of Clinical Neuroimmunology Ludwig Maximilian University and Munich Cluster for Systems Neurology (SyNergy) Munich Germany Max Planck Institute of Neurobiology, 82152 Martinsried, Germany 5; Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, 80539 Munich, Germany 6 From the Department of Neurology and Institute for Clinical NeuroimmunologyKlinikum Grosshadern, University of Munich, and Department of Neuroimmunology, Max Planck Institute for Neurobiology, Martinsried, Germany. Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians University Munich, 81377 Munich, Germany;; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians University Munich, 81377 Munich, Germany Departments of Neurology, Technische Universität Munich (Dr. Besinger) and Universität Düsseldorf (Drs. Heininger, Hömberg, Hohlfeld, and Toyka), and the Department of Clinical Chemistry, Grosshadern, Universität Munich (Dr. Fateh-Moghadam), West Germany. Institute of Clinical Neuroimmunology, Ludwig Maximilians University Munich, Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Ludwig Maximilians University Munich, Munich, Germany Institute for Clinical Neuroimmunology, Ludwig Maximilians University, D-81377 Munich, Germany;; Department of Neuroimmunology, Max Planck Institute for Neurobiology, D-82152 Martinsried, Germany; and From the Department of Neurology (P.J.T.), Biomedicum, Research Programs Unit, Molecular Neurology, Helsinki University Central Hospital and University of Helsinki, Finland; and the Institute of Clinical Neuroimmunology (R.H.), Ludwig Maximilians University, Munich, and Munich Cluster for Systems Neurology (SyNergy) (R.H.), Munich, Germany. Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University Munich and Munich Cluster Systems Neurology (SyNergy), Germany From the Division of Neuroimmunology, Department of Neurology, Department of Immunology and Microbiology, and the Multiple Sclerosis Center, Wayne State University School of Medicine and the Detroit Medical Center, Detroit, Michigan (Dr. Lisak); Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany, and the Department of Neuroimmunology, Max Planck Institute of Neurobiology, Martinsried, Germany (Dr. Hohlfeld). *Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilian University, 82152 Martinsried, Germany;; ‡‡Munich Cluster for Systems Neurology (SyNergy), 81377 Munich, Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Ludwig Maximilians University, Munich, Germany From the Department of Neurology (H.W.), Julius-Maximilians-University Würzburg, Germany; and the Institute of Clinical Neuroimmunology (R.H.), Ludwig Maximilians University of Munich, Germany. Institute of Clinical Neuroimmunology Klinikum Großhadern University of Munich Germany From the Institute of Clinical Neuroimmunology (R.H.), Ludwig Maximilians University, Munich; Munich Cluster for Systems Neurology (SyNergy) (R.H.), Germany; and University of Texas Southwestern Medical Center and Neurology Section (O.S.), VA North Texas Health Care Systems, Dallas. Ludwig-Maximilians-Universität München dDepartment of Neuroimmunology, Max-Planck-Institute for Neurobiology, 82152 Martinsried, Germany Institute of Clinical Neuroimmunology, University Hospital, Ludwig-Maximillians University, 81377 Munich, Germany;; Munich Cluster for Systems Neurology, Ludwig-Maximillians University, 81377 Munich, Germany; Munich Cluster for Systems Neurology, Ludwig Maximilian University of Munich, Munich, Germany Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, Germany; Munich Cluster for Systems Neurology (SyNergy), Germany From the Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, Klinikum Grosshadern, Munich, Germany, and the Department of Neuroimmunology, Max Planck Institute of Neurobiology, Martinsried, Germany. Institute of Clinical Neuroimmunology, Biomedical Center and Klinikum Grosshadern, Munich, Germany2Munich Cluster of Systems Neurology (SyNergy), Munich, Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany/The Munich Cluster for Systems Neurology (SyNergy), Munich, Germany From the Department of Neuroimmunology (Drs. Neuhaus, Farina, Wekerle, and Hohlfeld), Max-Planck Institute of Neurobiology, Martinsried; and the Institute for Clinical Neuroimmunology and the Department of Neurology (Dr. Hohlfeld), Ludwig Maximilians University, Munich, Germany. From the Institute of Clinical Neuroimmunology (G.R., A.G.N., K.S., R.H., K.D.) and Munich Cluster for Systems Neurology (SyNergy) (R.H., K.D.), Ludwig-Maximilian-University, Munich; Department of Life Sciences (A.P., M.K., I.A.), Technical University Munich, Freising; Max Planck Institute of Biochemistry (S.P.), Martinsried; Institute of Neuroimmunology and Multiple Sclerosis (M.A.F.), University Medical Centre, Hamburg-Eppendorf, Hamburg, Germany; MRC Human Immunology Unit (K.E.A.), Radcliffe... From the Institute of Clinical Neuroimmunology (K.H., L.B.-D., K.S., W.S., E.B., G.R., J.K.M.N., R.H., K.D.), Ludwig-Maximilians University, Munich, Germany; Neurologische Gemeinschaftspraxis (S.S.), Gesundheitszentrum St. Johannes Hospital, Bonn, Germany; Institute of Neuronal Cell Biology (P.E., T.M.), TU Munich, Munich, Germany; Department for Molecular Medicine (M.M.), Max-Planck-Institute of Biochemistry, Martinsried, Germany; Department for Neuroimmunology (W.E.F.K., H.W.), Max-Planck... From the Institute of Clinical Neuroimmunology (R.H., K.D.), Ludwig Maximilians University, Munich; and Department of Neuroimmunology (R.H., K.D.), Max Planck Institute of Neurobiology, Martinsried, Germany. Institute of Clinical Neuroimmunology University Hospital and Biomedical Center, Ludwig‐Maximilians University Munich Munich Germany; Munich Cluster for Systems Neurology (SyNergy) Munich Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany/ Munich Cluster of Systems Neurology (SyNergy), Ludwig-Maximilians-University Munich, Munich, Germany Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Munich, Germany Munich Cluster of Systems Neurology (SyNergy) Munich 81377 Germany; Institute of Clinical Neuroimmunology University Hospital Ludwig‐Maximilians‐Universität München Munich 81377 Germany From Montreal Neurological Institute (Dr. Karpati)McGill University, Montreal, Canada; and Institute for Clinical Neuroimmunology, Ludwig Maximilians University (Dr. Hohlfeld), Munich, Germany. From the Institute of Clinical Neuroimmunology (S.W., M. Schlüter, M. Spadaro, F.S.T., A.V., R.G., C.M., S.M., R.H., T.K., E.M.), Biomedical Center and University Hospitals, Ludwig Maximilian University Munich, Germany; Research Center for Translational Medicine (A.V.), Koç University School of Medicine, Istanbul, Turkey; Department of Neurology, (A.K., B.I., R.K.), Hacettepe University Faculty of Medicine, Ankara, Turkey; Department of Basic Oncology (F.G.Ö., G.E.), Hacettepe University Cancer... Institute of Clinical Neuroimmunology Biomedical Center and Hospital of the Ludwig‐Maximilians‐University Munich D‐82152 Munich Germany; Munich Cluster for Systems Neurology (SyNergy) D‐81377 Munich Germany From the Institute of Clinical Neuroimmunology, Ludwig Maximilians University of Munich, Munich, Germany. Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, Ludwig-Maximilians-Universität München, 82152 Munich, Germany Institute of Clinical Neuroimmunology, Biomedical Center, Ludwig Maxilimians University of Munich, Germany; Munich Cluster for Systems Neurology, (SyNergy), Munich, Germany From the Neuroimmunology Unit (J.A.), Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada; and Institute for Clinical Neuroimmunology (R.H.), Klinikum der LMU München, Munich, Germany. From the Department of Neurology (L.K.), University Hospital, Basel, Switzerland; St. Michael's Hospital (P.O.'C.), Toronto, Canada; Medical Image Analysis Centre (E.-W.R.), University Hospital, University of Basel, Switzerland; Department of Neurology (C.P.), VU University Medical Center, Amsterdam, Netherlands; Ludwig-Maximilians University of Munich and Munich Cluster for Systems Neurology (SyNergy) (R.H.), Germany; Department of Neurology (K.S.), Medical University of Lodz, Poland; Novartis... *Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, 81377 Munich, Germany;; ††Munich Cluster for Systems Neurology (SyNergy), 80336 Munich, Germany; Department of Neuroimmunology, Max Planck Institute for Neurobiology, Am Klopferspitz, D-82152 Martinsried, Germany; and Institute for Clinical Neuroimmunology, Ludwig Maximilians University, Klinikum Grosshadern, Marchioninistrasse 15, D-81366 Munich, Germany *Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals, LMU Munich, 82152 Planegg-Martinsried, Germany;; §Munich Cluster for Systems Neurology (SyNergy), LMU Munich and Technical University Munich, 81377 Munich, Germany Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University, 81377 Munich, Germany;; Munich Cluster for Systems Neurology (SyNergy), Ludwig-Maximilians-University, 81377 Munich, Germany *Max Planck Institute of Neurobiology, Martinsried, Germany;; †Institute for Clinical Neuroimmunology, Klinikum Groβhadern, Ludwig Maximilians University, Munich, Germany; *Institute of Clinical Neuroimmunology, Biomedical Center, University Hospital, Campus Martinsried-Grosshadern, Ludwig-Maximilians University, D-81377 Munich, Germany;; †Munich Cluster of Systems Neurology, 81377 Munich, Germany; and *Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Germany; and; †Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University, Munich, Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospitals Ludwig‐Maximilians‐Universität München Munich Germany; Munich Cluster for Systems Neurology Munich Germany Institute for Clinical Neuroimmunology, Ludwig Maximilians University, D-81377 Munich, Germany; Department of Neuroimmunology, Max Planck Institute for Neurobiology, 82152 Martinsried, Germany; and Institute for Genetics and Department of Dermatology, University of Cologne, 50931 Cologne, Germany Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, 81377 Munich, Germany; Max Planck Institute for Neurobiology, 82152 Martinsried, Germany; Department of Neurology, University of Bonn, 53127 Bonn, Germany; Department of Genetics and CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA 02115; and Department of Dermatology, University of Cologne, 50931 Cologne, Germany From the Mellen Center for Multiple Sclerosis (D.O., L.A.R.), Cleveland Clinic, OH; and Institute of Clinical Neuroimmunology (R.H.), Klinikum der LMU München, Germany. Department of Neuroimmunology, Max Planck Institute of Neurobiology, Am Klopferspitz 18, 82152 Martinsried, Germany;; Institute of Clinical Neuroimmunology, Ludwig-Maximilian-University, Marchioninistrasse 15, 81377 Munich, Germany; Institute of Clinical Neuroimmunology Biomedical Center and Hospital of the Ludwig‐Maximilians Universität München Munich Germany; Munich Cluster for Systems Neurology (SyNergy) Munich Germany From the Institute of Clinical Neuroimmunology (E.S., M.K., L.-A.G., R.H., T.K.), Institute of Clinical Radiology (B.E.-W.), and Department of Rheumatology (M.W.), Ludwig-Maximillians University, Munich, Germany; Department of Neuroimmunology (E.S.), Center of Brain Research, Vienna, Austria; Institute of Laboratory Medicine and Human Genetics (P.L.), Singen, Germany; Comprehensive Pneumology Center (M.F.) (Ludwig-Maximilians University Munich, Asklepios Kliniken Gauting, Helmholtz Zentrum München,... From the *Josef Lissner Laboratory for Biomedical Imaging, Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany; †Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom; ‡Institute for Clinical Radiology, and §Institute of Clinical Neuroimmunology, Ludwig-Maximilians-University Hospital; and ∥Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich D-81377, Germany. Department of Neuroimmunology, Max-Planck-Institute of Neurobiology, Martinsried, Munich, Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Grosshadern‐Martinsried Campus, Ludwig Maximilian University Munich; Munich Cluster of Systems Neurology (SyNergy) Munich Germany Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig Maximilians University, Munich, Germany/Munich Cluster for Systems Neurology (SyNergy), Munich, Germany Institute of Clinical Neuroimmunology, Ludwig Maximilian University and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany From the Institute of Clinical Neuroimmunology (E.S., R.H., T.K.) and Institute of Clinical Radiology (B.E.-W.), Ludwig-Maximilians University, Munich, Germany; Department of Neuroimmunology (E.S.), Center of Brain Research, Vienna, Austria; Institute of Laboratory Medicine and Human Genetics (P.L.), Singen, Germany; Department of Ophthalmology (W.W.), Outpatient Clinic Neuhann, Munich, Germany; Department of Nephrology (J.F.M.), Clinical Centre Schwabing, Munich, Germany; Department of Pediatrics ... Institute of Clinical Neuroimmunology, Ludwig Maximilians University of Munich, Department of Neuroimmunology, Max Planck Institute of Neurobiology, Martinsried, Germany, Department of Neuroimmunology, Max Planck Institute of Neurobiology, Am Klopferspitz 18A, 82152 Martinsried, Germany; Department of Statistics, Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany; and Institute for Clinical Neuroimmunology and Department of Neurology, Klinikum Grosshadern, Ludwig Maximilians University, Marchioninistrasse 15, 81366 Munich, Germany From the Institute for Clinical Neuroimmunology (R.H.), Munich, Germany; and Image Analysis Center (F.B.) and Department of Neurology (C.P.), VU University Medical Center, Amsterdam, the Netherlands. From the Institute of Clinical Neuroimmunology (M.S., L.A.G., M.K., F.S.T., E.S., R.H., E.M., T.K.), Department of Radiology (B.E.-W.), and Laboratory for Immunogenetics (A.D.), Medical Campus Großhadern, Ludwig-Maximilians-Universität München; Department of Neurology (M.K.), Hertie Institut für klinische Hirnforschung, Universitätsklinikum Tübingen; Department of Neuropathology (I.M., W.B.), University Medical Center, Georg August University, Göttingen; Department of Paediatric Neurology and... *Department of Neuroimmunology, Max-Planck Institute of Neurobiology, D-82152 Martinsried, Germany; and; †Department of Neurology, Klinikum Grosshadern, Munich, Germany *Institute of Clinical Neuroimmunology, Ludwig Maximilian University, Munich D-81377, Germany;; ¶¶Munich Cluster for Systems Neurology (SyNergy), Munich D-81377, Germany Department of Neurology (Drs. Hohlfeld, Heininger. and Toyka). University of Düsseldorf. and the Institute for Clinical Immunology (Drs. Kalies and Kohleisen), University of Erlangen, West Germany; and the Division of Chemistry (Dr. Conti-Tronconi). California Institute of Technology, Pasadena, CA. Institute of Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany;; Department of Neuroimmunology, Max Planck Institute of Neurobiology, Martinsried, Germany; Department of Neurology, Klinikum Groβhadern, University of Munich, D-81366 Munich and Department of Neuroimmunology, Max-Planck Institute, D-82152 Martinsried, Germany |
Incoming Links
Total number of triples: 333.